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1. Introduction

Over the past few years, the ability to readily harvest the extracellular matrix (ECM) of cells
has experienced many innovative developments that have led to an increase in the availability of
ECM for study and experimentation. This accessibility along with the long standing history of
the ECM as a potential biomaterial has turned into a growing movement to utilize and apply the
ECM and its byproducts to biomedical research and therapies [1]. A breadth of applications has
emerged spanning uses such as three-dimensional scaffolds in cell culture research to direct
medical procedures implemented as fillers for ostechondral defects and the creation of cardiac
and vasculature reconstructive tissue for implantation [2]. The adaptable nature of the ECM
along with its favored properties of biodegradation and biocompatibility make it highly desirable
as an implantable biomaterial, but problems have arisen during its implementation that have
hampered its therapeutic potential. In particular, one of the greatest benefits with of ECM-based
implantations may also be one of the greatest limiting factors –the short time in which it is
biodegraded or resorbed [3]. As the body has the ability to produce ECM, so it too possesses the
ability to resorb it which it readily does when large quantities of implanted ECM are introduced
in vivo. A pharmaceutical or chemical treatment to improve the functional time of implantable
ECM is potentially available, but there exists a need for a cost effective, in vitro model to
evaluate these inhibitory agents for their ability to hamper ECM degradation.

1.1 The Physiological Environment of Extracellular Matrix
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The extracellular matrix is not definable by its material alone as its composition can differ
depending on the microenvironment of the body or organism that houses it. Instead, the ECM is
most definable by its functional characteristics including its abilities to allow cellular adhesion,
provide structure, and even act as a repertoire for intercellular signals such as growth factors [3].
That being said, all ECM shares some common compositional components with the most
abundant of these being the structural proteins- collagen and elastin- and the adhesive proteinsfibrinogen and laminin [4]. In particular, collagen is the most common underlying protein found
in ECM comprising up to 90% of the dry weight in some tissues [5]. Collagen is subdivided into
twenty-eight types to better distinguish among its structures and functions. The most widespread
of these functioning in the ECM are types I and III [5] utilized in a span of biological locations
ranging from structure of skin, vasculature, interstitial tissue, granulation tissue and scar tissue
[6]. Due to this prevalence throughout the body, collagen is one of the major targets of
reconstruction since it comprises most of the structure of the ECM. It was for this reason that the
model system to evaluate ECM degradation used DQ collagen as an analog. DQ collagen is a
collagen conjugate molecule that susceptible to all the same enzymes of natural collagen (Figure
1). It is conjugated with a fluorescent molecule that is only exposed when the DQ collagen is
cleaved, allowing variations in the level of collagen degradation to be evaluated by measuring
changes in expressed fluorescence [7]. The molecules that cause this degradation are naturally
occurring proteins called matrix metalloproteases (MMP) which can be found anywhere there is
ECM reconstruction.
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Figure 1. Representation of DQ collagen structure before and after degradation by MMPs. Before degradation, fluorescent
signal is quenched by close proximity of fluorescent molecules on the intact collagen [7]. As MMPs degrade the collagen
structure, more fluorescent molecules are exposed resulting in a greater signal. Ownership of graphic belongs to
http://aetherforce.com/how-fluorescent-light-works/.

These MMPs operate with the use of a catalytic Zn2+ active site in their structure

allowing the hydrolysis of ECM proteins [8]. The MMP group that specifically degrades
collagen is known as the collagenases. The collagenases operate as endopeptidases cleaving
collagens I, II, and III at an interior-domain site marked by the N-terminus [8]. Due to the
effectiveness of MMPs at low concentrations over short time intervals, they are synthesized as
zymogens that must have a section of the pro-peptide domain removed in order for the zincdependent active site to become available [8]. In addition, members of another family of
proteins known as the tissue inhibitors of metalloproteinase (TIMPs) are produced in areas of
reconstruction to keep MMP activity in check. Physiological conditions of reconstruction that
lead to matrix metalloproteases synthesis are angiogenesis, wound healing, and tissue
remodeling for growth or normal wear.
The cells responsible for ECM reconstruction are known as fibroblasts. These cells
produce and export both the proteins that comprise the ECM as well as the MMPs that help
remove them. To accommodate this high level of protein secretion, fibroblasts are characterized
by extensive endoplasmic reticulum and long, branched cytoplasm. Their primary goal is to
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maintain the structure of the ECM and as such they are found in connective tissues and in sites of
wound healing. In the model of ECM degradation, 3T3 cells were used as analogs for a potential
reconstructive environment. The 3T3 cells are fibroblasts capable of both ECM secretion and
the ability to secrete collagen degrading MMPs that are necessary to break down the structure of
DQ collagen [9].

1.2 Potential Control Mechanisms for Degradation of Extracellular Matrix Implants

In order to lengthen the functional time of implantable ECM, the mechanism of
degradation must be inhibited. The matrix metalloproteases are the primary method by which
ECM is broken down, and the TIMP family of proteins exists as proof that inhibition of these
proteases is possible naturally. In particular, the glycoprotein TIMP-1 plays an inhibitory role
with most of the MMPs including the collagenases [10]. Furthermore, there exist synthetic or
chemical molecules that likewise inhibit the catalytic actions of MMPs. One such molecule is
Batimastat (BB-94) which has been proven to be a dose dependent inhibitor of MMPs during the
inflammatory response [11]. In order to evaluate the potential to increase the effective time of
ECM based implants, an in vitro assay was developed to monitor the natural degradation rate of
ECM in culture with DQ collagen and 3T3 fibroblasts. The protein TIMP-1 and the molecule
BB-94 were incorporated into this model to evaluate their potential use in controlling the
degradation rate of ECM implants.

2. Methods
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2.1 Preparation of Foam Scaffold and Well Plates

Foam scaffolds were prepared by first creating a polymer solution of polyurethane and
DMAC. The solution was prepared with 2g of polyurethane beads being allowed to dissolve
completely in 20 mL of DMAC over a 24 hour period. The next step involved mixing 10 grams
of table sugar with 200 μL of deionized water to create a sugar slurry. The sugar slurry was
spread into molds -dimension 15 mm diameter by 1 mm height- sized for use in twenty-four well
plates. The molds were then placed into an oven at 60 degrees centigrade for 20 minutes to
allow some of the excess water to evaporate off. At this point the polymer solution was applied
to sugar filled molds until the molds were filled. This required between an average of 1.2 to 1.4
mL of polymer solution per well. The polyurethane foams were then submerged in deionized
water for 24 hours at room temperature. Following the first 24 hour period, the now solid and
porous polyurethane foams were removed from their molds and placed in a separate DI water
bath at room temperature. The new bath was stirred constantly, and the DI water was changed
every 8 hours for another 24 hour period to remove all traces of remaining sugar. The foams
were then removed from the bath and placed 8 apiece into 50 mL centrifuge tubes and allowed to
freeze overnight in a -25 degree centigrade freezer. After the foams were completely frozen,
they were lyophilized for another 24 hours. The foams were stored sealed at room temperature
until placed into a twenty-four well plate and sterilized using gas sterilization.

2.2 Cell Culture
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Frozen vials of 3T3 fibroblasts were thawed in 37 C water bath and added to 16 mL of
warm media at same temperature in a T-175 flask. Following seeding, cells were incubated for
45 minutes at 37 C. The media was then removed and replaced so only the cells that adhered to
the flask would remain. Cells were incubated at 37 C. Cells were fed every 24 hours with a
fresh 17 mL of media until confluence. Average times of confluence ranged between 5-7 days.
Following confluence, cells were then split into three flasks. After removing all media
from the flask, trypsin EDTA (7 mL) was added and allowed to incubate with the cells for 15
minutes. After this time, 7 mL of warm media were added to neutralize the trypsin. The
resulting 14 mL solution was put into a centrifuge vial and spun down at 300 G for 5 minutes.
The remaining solution was removed and the resulting pellet was re-suspended in 12 mL of
media. This new solution was added to 3 T-175 flasks (4 mL each) along with 13 mL warm
media. These flasks were cultured using the above steps until confluence.

2.3 Well Plate Preparation

Foams that had been gas sterilized were treated with fibronectin before cells were seeded
onto them. To start, the sterile foams were rinsed with 500 μL of sterile PBS and left to sit for 5
minutes. The foams were each rinsed a total of three times. Fibronectin solution (500 μL) was
then applied to the foams. Well plates were wrapped in para-film and stored cold for 36 hours.
Cells were removed from T-175 flasks using steps described in 2.2. Following removal,
the cells were counted using a hemocytometer. A total of 8 million cells were seeded per foam
and warm media was added until the total solution in each individual well was 500 μL. The well
plates were then incubated for 24 hours at 37 C.
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2.4 Testing for Signal to Noise

Two well plates were used for this test. One well plate had half of its wells left without
foams in order to establish controls on the degradation rate of the DQ collagen. The DQ
collagen was prepared in three concentrations of 2 μg/mL, 10 μg/mL, and 50 μg/mL. A total of
nine foams would be exposed to each concentration over a period of 4 days. The first three
foams from each concentration (n=3) would be sampled after 24 hours, the next three foams
would be sampled after 48 hours, and the final 3 foams would be sampled at 96 hours along with
each of the foamless control wells. To sample the wells, three 100 μL samples were taken from
the 500 μL solution in each well. The 100 μL samples were put into a 96 well plate. Fluorescent
readings were taken on days 1, 2 and 4 with excitation wavelengths at 485/20 nm and emission
wavelengths at 528/20 nm to best comply with manufacturer’s suggestions. Foams were
removed from original plate at time of sampling and placed into a new sterile well plate before
being suspended in 10% formalin. DAPI staining was performed on foams to make sure cell
adhesion had taken place and the well samples were valid (Figure 2). Test was repeated twice.
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Figure 2. Representation of DAPI staining results from the seeded foam scaffoldings that had participated in the assay.
Foam A is an example of a foam that was successfully seeded as seen by the prevalence of distinguishable nuclei visible on
the polyurethane foam. Foam B is an example of a foam that was eliminated from the assay for failure to seed any cells.

2.5 Effect of TIMP-1 and BB-94 on MMP Inhibition

Similar to the signal to noise test, two 24 well plates were used for this test. All foams in
this test received DQ collagen at the concentration and for the amount of time that yielded the
greatest signal to noise ratio in the previous tests. TIMP-1 working solution was prepared with
sterile PBS to form concentrations of 2 ng/mL, 10 ng/mL, and 100 ng/mL when added to the 500
μL of media in each well. Batimistat was made into working solution with DMSO at
concentrations of 10 nM, 100 nM, and 1000 nM when added to the 500 μL of media in each
well. BB-94 solution was added so that the total amount of solution in the well was less than 5%
DMSO do minimize its effects on the cells. The DMSO was also sterile filtered to minimize
chance of contamination.
One well plate was filled with seeded foams. Each column corresponded to one of the
concentrations of BB-94 or TIMP-1 listed above (n=4). Only eight foams were added to the
other plate which received no MMP inhibitor. Samples were taken in the same manner as in 2.4.
Following the sample collection phase, foams were fixed in 10% formalin in a new well plate.
Foams were DAPI stained to check for cellular adhesion to the foam. Sample foams without cell
adhesion were eliminated from being represented in the final results.

2.6 Statistical Analysis
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All data sets are represented by the mean and standard deviation. Comparisons between
samples groups were evaluated using a student's t-test. A standard 0.05 level of significance was
used for all statistical tests.

3. Results

The first phase of experimentation was
performed in order to find an acceptable
signal to noise ratio of testing over a period of
four days. Readings were taken on days 1, 2,
and 4. The first run had two samples that
performed differently than the controls at the
level of statistical significance (Figure 3). The
first occurred at day 2 at a concentration of 50
ug/mL. The mean value of the sample was
1612 ± 18.76 while the mean for the control
was 1409 ± 16.08 giving < 1% chance that the
two groups were the same. The second
notable sample occurred on day 4 at the
concentration of 50 ug/mL DQ collagen. The
mean value of the sample was 2292 ± 102.4
with the mean of the control being 1427 ±

Figure 3. Fluorescent values for concentration of DQ
collagen in presence of fibroblasts, first run. Only 50
ug/mL in B and C were shown to be statistically significant
with signal to noise ratios of about 8:7 and 2:1
respectively.
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50.76 also giving < 1% probability that the two groups were the same.
The second run of the assay likewise resulted in two samples that displayed significantly
different fluorescent values. However, both of these samples appeared only on the fourth day of
evaluation (Figure 4). The first was the 2
ug/mL concentration of DQ collagen at an
average of 412 ± 23.96 for the sample and an
average of 277.7 ± 3.858 giving < 1% chance
that the sample and control were the same.
The second was at the 50 ug/mL concentration
at an average of 2717 ± 233.8 for the sample
with the control averaging at 2048 ± 31.51
yielding a probability of < 1% that the two
groups were the same. From the above assays
it was decided that the most substantial signal
to noise ratio existed at the fourth day at 50
ug/mL of DQ collagen since both assays
displayed statistical significance at these
points.
The final test was used to determine
the effectiveness of BB-94 and TIMP-1 to
prevent collagen degradation (Figure 5). From
the two MMP inhibitors, there were a total of
three concentrations that were shown to be

Figure 4. Fluorescent values for concentration of DQ
collagen in presence of fibroblasts, second run. Two
samples in C at 2 and 50 ug/mL were shown to be
statistically significant with signal to noise ratios of about
4:3 and 7:5 respectively.
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statistically less degraded than the controls. The first was the only concentration of TIMP-1 that
was shown to be potentially significant, and it occurred at the lowest concentration of only 1
ng/mL. The mean of this TIMP-1 sample was 1878 ± 62.56 as compared to the controls mean of
2252 ± 175.9 giving a probability value of < 5%. Batimistat was shown to reduce degradation at
concentrations of 100 nM and 1000 nM. The mean fluorescent value at 100 nM was 1832 ±
109.2 while the mean value for 1000 nM was 1751.5 ± 158.6 showing that both had < 5%
probability of being from the control group.

Figure 5. Results of assay testing with inhibitory agents BB-94 (A) and TIMP-1 (B). BB-94 showed significant results at 100
nm and 1000 nm with means of 1832 ± 109.2 and 1751.5 ± 158.6 respectively. TIMP-1 only was shown to be successful in
MMP inhibition at 1 ng/mL concentration with a mean of 1878 ± 62.56. The control group represented had a mean of 2252
± 175.9, which is higher than in either of the previous assays.

4. Discussion

The signal to noise ratio collected from the first two assays was most acceptable for the
time period of 4 days at a concentration of DQ collagen at 50 ug/mL. Both assays showed that
this result was statistically significant from the control populations, and was visibly more
distinguishable when plotted due to a larger difference in the mean fluorescent values. A
possible explanation for these results is the higher concentration of DQ collagen was likely more
sensitive to the MMPs secreted by the 3T3 cells since the chances of an MMP finding a binding
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site to initiate cleavage were greater. The 4 day time period allowed the cells to be metabolically
active longer thereby increasing the concentration of functional MMPs in the model.
When the inhibitory molecule BB-94 and the MMP inhibitor protein TIMP-1 were
introduced, the results displayed distinctive patterns of success. The assay displayed a pattern of
increasing inhibition effectiveness with an increase in concentration of BB-94. Batimistat was
successful in the inhibition of MMPs at concentrations of both 100 nM and 1000 nM. Although
these two groups were independent of the control group, they were statistically similar
potentially implying that the most efficient concentration of BB-94 lies at or around 100 nM with
diminishing returns resulting from introducing higher concentrations of the drug. However,
more testing would be needed to support this hypothesis. TIMP-1 yielded surprising results with
only the lowest concentration being statistically successful at inhibition when compared to the
controls. A caveat to this result is that the populations of TIMP-1 concentrations were
statistically indistinguishable from one another with a much more comparable mean than the BB94 populations. The results also do not indicate that increasing the concentration of TIMP-1 will
have any effect on the inhibition of MMPs within the scope of concentrations tested.
This particular run of the assay was limited by the inclusion of only fibroblasts within the
model. When dealing with ECM reconstruction in vivo, there are other cell types that would
contribute to the body’s response to an implant, namely macrophages and endothelial cells.
Macrophages are common responders to all medical implants in vivo since they are mediators of
the inflammatory response to foreign material [12]. Endothelial cells are found throughout the
body in various forms, but mainly serve to regulate vasculature systems through protein
expression including the excretion of MMPs during reconstructive events such as angiogenesis
[13]. Although the model did not include these cells initially, it is easily adaptable to
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accommodate them in future iterations since the structural foam for cell seeding is coated in
fibronectin, a glycoprotein known to attach both endothelial cells and macrophages [14]. Other
inhibitory molecules or proteins can likewise be readily incorporated into the assay since the
setup in not inherently dependent on the choice of inhibitor molecule. Further testing could also
be done employing therapeutic MMP inhibitors already approved by the FDA such as Periostat
[15] or developing therapeutics such as the breast cancer treatment drug Tanomastat [16].
Overall, the assay proved to be successful in its ability to determine the effectiveness of MMP
inhibitors as potential protectors to ECM based biomaterials by showing the inhibitory effects of
BB-94 and TIMP-1. Furthermore, it displays a degree of versatility that will allow it to be
utilized in successive evaluations of inhibitory molecules and proteins.
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